Table 4.
Relationships between biofilm, clinical characteristics of patients, and symptomatic data
| Characteristics and symptomatic data | No. (%) with biofilm: |
Total (no. [%]) (n = 66 [100%]) | P | |
|---|---|---|---|---|
| Present (n = 23 [35%]) | Absent (n = 43 [65%]) | |||
| Length of evolution | ||||
| <6 wk | 2 (50) | 2 (50) | 4 | 0.57 |
| 6 wk to 8 mo | 9 (42.9) | 12 (57.1) | 21 | |
| >8 mo | 11 (31.4) | 24 (68.6) | 35 | |
| Chemotherapy | ||||
| No | 0 | 6 (100) | 6 | 0.16 |
| Yes | 16 (33.3) | 32 (66.7) | 48 | |
| Aplasia | ||||
| No | 11 (28.9) | 27 (71.1) | 38 | 0.8 |
| Yes | 5 (31.2) | 11 (68.8) | 16 | |
| Odors | ||||
| Absence | 5 (21.7) | 10 (23.3) | 15 (22.7) | 0.88 |
| Presence | 18 (78.3) | 33 (76.7) | 51 (77.3) | |
| Exudates | ||||
| Weak/absent | 3 (13) | 9 (20.9) | 12 (18.2) | 0.64 |
| Moderate/strong | 20 (87) | 34 (79.1) | 54 (81.8) | |
| Pain | ||||
| Absence | 6 (26.1) | 14 (32.6) | 20 (30.3) | |
| Weak | 8 (34.8) | 17 (39.5) | 25 (37.9) | 0.58 |
| Moderate | 3 (13) | 9 (20.9) | 12 (18.2) | |
| Strong | 3 (13) | 2 (4.7) | 5 (7.6) | |
| Intense | 3 (13) | 1 (2.3) | 4 (6.1) | |
| Provoked bleeding | ||||
| Absence | 11 (47.8) | 11 (25.6) | 22 (33.3) | 0.06 |
| Presence | 12 (52.2) | 32 (74.4) | 44 (66.7) | |